We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

139 hedge funds and large institutions have $472M invested in Ventyx Biosciences in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 30 increasing their positions, 41 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

246% more capital invested

Capital invested by funds: $136M → $472M (+$335M)

132% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 22

26% more funds holding

Funds holding: 110 → 139 (+29)

11.69% more ownership

Funds ownership: 61.5% → 73.19% (+12%)

27% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 41

73% less call options, than puts

Call options by funds: $6.55M | Put options by funds: $23.8M

Holders
139
Holders Change
+29
Holders Change %
+26.36%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
51
Increased
30
Reduced
41
Closed
22
Calls
$6.55M
Puts
$23.8M
Net Calls
-$17.3M
Net Calls Change
-$17.7M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$30.3M
2
AAA
Affinity Asset Advisors
New York
+$19.1M
3
BlackRock
BlackRock
New York
+$14.6M
4
B
Braidwell
Connecticut
+$14.4M
5
MB
MPM BioImpact
Massachusetts
+$12.2M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$16.1M
2
SAM
Sectoral Asset Management
Quebec, Canada
-$7.55M
3
Marshall Wace
Marshall Wace
United Kingdom
-$7.2M
4
VPC
Vestal Point Capital
New York
-$6.38M
5
JP Morgan Chase
JP Morgan Chase
New York
-$5.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$4.86M +$2.26M +303,071 +129%
BNP Paribas Financial Markets
27
BNP Paribas Financial Markets
France
$4.08M +$3.38M +452,069 +187,580%
NAMI
28
Nomura Asset Management International
Pennsylvania
$3.88M +$3.21M +430,000 New
SCM
29
Squadron Capital Management
Illinois
$3.7M +$3.06M +410,000 New
SCM
30
Sio Capital Management
New York
$3.5M -$3.3M -441,427 -53%
Charles Schwab
31
Charles Schwab
California
$3.46M -$107K -14,358 -4%
Adage Capital Partners
32
Adage Capital Partners
Massachusetts
$3.39M +$2.8M +375,000 New
Two Sigma Investments
33
Two Sigma Investments
New York
$3.25M -$569K -76,152 -17%
Bank of America
34
Bank of America
North Carolina
$2.86M -$1.59M -212,393 -40%
TCM
35
TCG Crossover Management
California
$2.86M – – –
Qube Research & Technologies (QRT)
36
Qube Research & Technologies (QRT)
United Kingdom
$2.47M +$948K +126,839 +87%
MAP
37
Moody Aldrich Partners
Massachusetts
$2.37M +$1.97M +262,938 New
BFM
38
Boothbay Fund Management
New York
$2.28M -$1.35M -180,533 -42%
OM
39
Opaleye Management
Massachusetts
$2.27M +$1.88M +251,932 New
IG
40
ING Group
Netherlands
$2.16M +$1.79M +239,000 New
BCM
41
Bridgeway Capital Management
Texas
$2.11M – – –
Wellington Management Group
42
Wellington Management Group
Massachusetts
$2.05M +$1.7M +227,229 New
DP
43
Diadema Partners
New Jersey
$1.81M +$963K +128,796 +181%
SFM
44
Sphera Funds Management
Israel
$1.63M -$1.94M -260,000 -59%
GCP
45
GSA Capital Partners
United Kingdom
$1.56M -$522K -69,866 -29%
SPS
46
Susquehanna Portfolio Strategies
Pennsylvania
$1.53M – – –
Two Sigma Advisers
47
Two Sigma Advisers
New York
$1.41M -$1.2M -160,000 -51%
PFS
48
Prospera Financial Services
Texas
$1.37M +$13.2K +1,770 +1%
CFG
49
Citizens Financial Group
Rhode Island
$1.28M – – –
Northern Trust
50
Northern Trust
Illinois
$1.22M +$37K +4,950 +4%
1
2
3 4 5

VTYX Hedge Fund Activity: Q4 2025 in Review

139 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q4 2025, worth a combined $472M — up 246% from $136M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new VTYX positions and 22 closed out — a net gain of 29 holders — while 30 added to existing stakes and 41 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $30.3M. The largest seller was Point72 Asset Management, cutting an estimated $16.1M.

  • 139 institutional investors held Ventyx Biosciences (VTYX) as of Q4 2025, up from 110 in Q3 2025.
  • Funds reported $472M of Ventyx Biosciences stock for Q4 2025, up 246% quarter-over-quarter.
  • 51 funds opened new Ventyx Biosciences positions in Q4 2025 and 22 closed out, a net change of +29 holders.
  • The largest Ventyx Biosciences buyer in Q4 2025 was Morgan Stanley, an estimated $30.3M added.
  • The largest Ventyx Biosciences seller in Q4 2025 was Point72 Asset Management, an estimated $16.1M sold.

Based on aggregated 13F filings for Q4 2025.